COMP <GO>
KTOS vs TMO // REVENUE GROWTH (YOY)
Kratos Defense & Security Solutions Inc. (NASDAQ) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: KTOS 3
— TMO 12
▲ REVENUE GROWTH (YOY) LEADER: KTOS
LAST: $41.09 (-5.74%) • MKT CAP: $8.18B
revenue-growth
18.50%
LAST: $697.00 (-1.72%) • MKT CAP: $262.22B
revenue-growth
3.90%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (KTOS VS. TMO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | KTOS | TMO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 22.90% | 41.00% | -18.10 | TMO | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 1.40% | 9.30% | -7.90 | TMO | /roic <GO> |
| EV/EBITDA & P/E Valuation | 95.0x | 30.4x | +64.60 | TMO | /valuation <GO> |
| Free Cash Flow Yield | -1.26% | 2.40% | -3.66 | TMO | /fcf-yield <GO> |
| Operating Margin | 1.90% | 17.40% | -15.50 | TMO | /operating-margins <GO> |
| Net Profit Margin | 1.60% | 15.10% | -13.50 | TMO | /net-margins <GO> |
| Revenue Growth (YoY) ACTIVE | 18.50% | 3.90% | +14.60 | KTOS | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.24% | -0.24 | TMO | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 11.11 | 4.50 | +6.61 | KTOS | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | 8/9 | -3.00 | TMO | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.90% | 6.70% | +0.20 | TMO | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 45.9 | 59.1 | -13.30 | TMO | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.01 | 0.94 | +0.07 | KTOS | /macro-sensitivity <GO> |
| Forward P/E Multiple | 140.0x | 36.3x | +103.70 | TMO | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $8.18B | $262.22B | -$254.03B | TMO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | KTOS REV | TMO REV | KTOS GROSS % | TMO GROSS % | KTOS FCF | TMO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.35B | $44.56B | 22.9% | 44.0% | -$102.7M | $6.29B |
| FY 2024 | $1.14B | $42.88B | 25.3% | 44.0% | -$1.4M | $7.27B |
| FY 2023 | $1.04B | $42.86B | 44.0% | 44.0% | $18.5M | $6.48B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
KTOS // BETA 1.01
TMO // BETA 0.94